Global Molecular Diagnostics Market Analysis to 2022 – Molecular Diagnostics Take the Center Stage in COVID-19 Testing

by NASDAQ Market News June 17, 2020

NASDAQ Market News
Click here to email author

Affimed Announces Successful Completion of First Dose Cohort in First-in-Human Phase 1/2A Study of AFM24 for the Treatment of Advanced EGFR-Expressing Solid Tumors Including Colon, Lung and Other Cancers

The Global Veterinary Immunodiagnostics Market is poised to grow at a CAGR of around 9.6% by 2028

Ads